CD44 and Alzheimer disease: SDC3, a transmembrane heparan sulfate proteoglycan, was suggested to act as an important modulator of synaptic plasticity that influences mouse hippocampus-dependent spatial memory [56], and also could serve as an emerging molecular target in AD in mice [57].